This new report from Venture Planning Group provides strategic assessments of major suppliers of infectious deisease instuments and reagants, as well as emerging market entrants.
The report presents strategic assessments of leading market players and emerging suppliers with innovative technologies and products in terms of their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Contains 90 pages